دورية أكاديمية
COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence.
| العنوان: | COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence. |
|---|---|
| المؤلفون: | Abdelzaher H; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Saleh BM; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Ismail HA; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Hafiz M; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Gabal MA; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Mahmoud M; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Hashish S; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Gawad RMA; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Gharieb RY; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Abdelnaser A; School of Science and Engineering, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt. |
| المصدر: | Frontiers in pharmacology [Front Pharmacol] 2020 Oct 07; Vol. 11, pp. 579415. Date of Electronic Publication: 2020 Oct 07 (Print Publication: 2020). |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Media] |
| مستخلص: | The Covid-19 pandemic is with no doubt the biggest health crisis of the 21 st century. The disease is caused by a virus of the Coronaviridae family and is closely related to the virus responsible for the severe acute respiratory Syndrome (SARS). Since December 2019, the virus has continued to spread way beyond the location of the first recorded cases (Wuhan, China). As of now, over 5 million cases have been diagnosed with the disease worldwide and over 300 thousand have died. COVID-19 patients suffer from respiratory symptoms that can rapidly turn into potentially fatal acute respiratory distress syndrome (ARDS) in a portion of patients. Although many drugs and vaccines are currently under clinical trials, there is no currently approved treatment or vaccine. It is therefore critical to correctly identify risk factors that lead to the exacerbation of symptoms in highly susceptible groups. Groups that are at high risk include those aged 55 or older especially those with underlying conditions such as cardiovascular diseases. Certain ethnicities such as African-Americans have been found to be at a higher risk and males seem to be higher both in numbers as well as severity of cases. It is hypothesized that these groups are at risk as their molecular landscape is more permissive of viral infection and growth. Different occupations, especially those related to health-care as well as populations that do not cultivate a mask-wearing culture are at higher risk due to environmental exposure. In this article, we examine the evidence regarding different groups that are more sensitive to the disease and review hypotheses pertaining to COVID-19 infection and prognosis. Risk factors that can be related to the molecular landscape of COVID-19 infection as well as those related to environmental and occupational conditions are discussed. (Copyright © 2020 Abdelzaher, Saleh, Ismail, Hafiz, Gabal, Mahmoud, Hashish, Gawad, Gharieb and Abdelnaser.) |
| References: | Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076) N Engl J Med. 2020 Apr 30;382(18):e41. (PMID: 32212516) J Infect. 2020 May;80(5):e1-e6. (PMID: 32171869) N Engl J Med. 2020 Apr 23;382(17):1653-1659. (PMID: 32227760) Turk J Med Sci. 2020 Apr 18;50(SI-1):592-603. (PMID: 32304191) J Virol. 2010 Apr;84(7):3134-46. (PMID: 19906932) Nature. 2020 Mar;579(7798):270-273. (PMID: 32015507) Cureus. 2020 Mar 21;12(3):e7355. (PMID: 32328367) Occup Med (Lond). 2020 Mar 12;70(1):3-5. (PMID: 32107548) J Med Virol. 2020 Jun;92(6):568-576. (PMID: 32134116) Drug Saf. 2020 Aug;43(8):809-821. (PMID: 32578156) Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145) JAMA. 2020 May 19;323(19):1912-1914. (PMID: 32221579) Lancet Respir Med. 2020 May;8(5):434-436. (PMID: 32203710) Lancet. 2020 May 30;395(10238):1705-1714. (PMID: 32416785) Fetal Pediatr Pathol. 2020 Jun;39(3):246-250. (PMID: 32238084) J Thromb Haemost. 2014 Feb;12(2):214-9. (PMID: 24283769) N Engl J Med. 2013 Jun 6;368(23):2159-68. (PMID: 23688302) N Engl J Med. 2020 Jun 18;382(25):2441-2448. (PMID: 32356628) PLoS One. 2020 Apr 28;15(4):e0232452. (PMID: 32343747) N Engl J Med. 2020 Mar 26;382(13):1199-1207. (PMID: 31995857) Eur Heart J. 2020 May 14;41(19):1798-1800. (PMID: 32186331) Am J Respir Crit Care Med. 2020 Jul 1;202(1):83-90. (PMID: 32348692) Br J Haematol. 2020 Jun;189(6):1044-1049. (PMID: 32330308) Occup Med (Lond). 2020 Jul 17;70(5):315-316. (PMID: 32359148) Lancet. 2020 Mar 21;395(10228):945. (PMID: 32142626) Lancet. 2020 Apr 11;395(10231):1225-1228. (PMID: 32178769) Lancet. 2020 Feb 15;395(10223):470-473. (PMID: 31986257) Int J Occup Environ Health. 2004 Oct-Dec;10(4):421-7. (PMID: 15702757) Mil Med Res. 2020 Mar 13;7(1):11. (PMID: 32169119) Cell Res. 2017 Jan;27(1):119-129. (PMID: 28008928) Can J Cardiol. 2020 Jun;36(6):915-930. (PMID: 32439306) JAMA. 2020 Mar 17;323(11):1061-1069. (PMID: 32031570) J Allergy Clin Immunol Pract. 2020 Jul - Aug;8(7):2152-2155. (PMID: 32360185) Dev Cell. 2020 Jun 8;53(5):514-529.e3. (PMID: 32425701) Acta Paediatr. 2020 Jun;109(6):1088-1095. (PMID: 32202343) Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. (PMID: 32663409) MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):312-313. (PMID: 32191689) Lancet. 2022 Apr 30;399(10336):e39-e40. (PMID: 32305074) N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013) J Mol Cell Cardiol. 2016 Aug;97:180-90. (PMID: 27210827) MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426. (PMID: 32271728) N Engl J Med. 2020 Apr 2;382(14):1370-1371. (PMID: 32163697) N Engl J Med. 2012 Nov 8;367(19):1814-20. (PMID: 23075143) Annu Rev Virol. 2016 Sep 29;3(1):237-261. (PMID: 27578435) Scand J Work Environ Health. 2020 May 1;46(3):229-230. (PMID: 32356896) Tuberculosis (Edinb). 2009 Jul;89(4):248-51. (PMID: 19540166) Fertil Steril. 2020 Jun;113(6):1135-1139. (PMID: 32482249) JAMA. 2020 Apr 28;323(16):1612-1614. (PMID: 32191259) Proc Natl Acad Sci U S A. 2020 May 5;117(18):9696-9698. (PMID: 32300018) Int J Infect Dis. 2020 Jul;96:459-460. (PMID: 32464271) J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. (PMID: 32238757) Lancet. 2020 May 16;395(10236):1569-1578. (PMID: 32423584) J Hosp Infect. 2020 Aug;105(4):596-600. (PMID: 32565367) Saf Sci. 2020 Sep;129:104830. (PMID: 32406406) Travel Med Infect Dis. 2020 Mar - Apr;34:101649. (PMID: 32234457) J Infect Public Health. 2020 Jul;13(7):901-905. (PMID: 32534946) Ann Intern Med. 2020 Sep 15;173(6):474-481. (PMID: 32501754) Clin Infect Dis. 2020 Jul 28;71(15):844-846. (PMID: 32119083) JAMA. 2020 Apr 14;323(14):1406-1407. (PMID: 32083643) Sci Adv. 2020 Jul 1;6(27):. (PMID: 32937441) Blood Res. 2019 Sep;54(3):175-180. (PMID: 31730677) Nanomaterials (Basel). 2020 Apr 21;10(4):. (PMID: 32326343) J Hum Hypertens. 2020 Jun;34(6):415-417. (PMID: 32409727) J Virol. 2020 Mar 17;94(7):. (PMID: 31996437) Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2005-2011. (PMID: 32638221) Nat Med. 2020 May;26(5):676-680. (PMID: 32371934) Br Med Bull. 2019 Mar 1;129(1):69-78. (PMID: 30649219) J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. (PMID: 32201335) J Am Acad Dermatol. 2020 Jul;83(1):e35. (PMID: 32305444) J Obstet Gynaecol Res. 2020 Aug;46(8):1235-1245. (PMID: 32500549) Drug Saf. 2020 May;43(5):393-394. (PMID: 32266694) JAMA. 2020 Jul 14;324(2):168-177. (PMID: 32558877) N Engl J Med. 2020 Mar 26;382(13):1268-1269. (PMID: 32109011) Nat Med. 2020 May 15;:. (PMID: 32415251) MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386. (PMID: 32240123) Intensive Care Med. 2020 May;46(5):833-836. (PMID: 32125458) J Immunol Res. 2020 Jul 10;2020:1357983. (PMID: 32671115) Occup Med (Lond). 2020 Jul 17;70(5):349-351. (PMID: 32347933) Int J Biol Sci. 2020 Mar 15;16(10):1745-1752. (PMID: 32226294) Am J Obstet Gynecol MFM. 2020 Aug;2(3):100145. (PMID: 32427221) J Hypertens. 2004 Oct;22(10):1971-6. (PMID: 15361769) Lancet. 2020 May 22;:. (PMID: 32450107) Lancet Infect Dis. 2020 Dec;20(12):1365-1366. (PMID: 32359410) Viruses. 2020 Apr 10;12(4):. (PMID: 32290077) Lancet. 2003 Oct 25;362(9393):1353-8. (PMID: 14585636) Infect Control Hosp Epidemiol. 2020 Oct;41(10):1196-1206. (PMID: 32408911) Hypertens Res. 2020 Jul;43(7):648-654. (PMID: 32341442) Anesthesiology. 2020 Jun;132(6):1317-1332. (PMID: 32195705) Prog Cardiovasc Dis. 2020 May - Jun;63(3):386-388. (PMID: 32220590) JAMA. 2020 May 12;323(18):1775-1776. (PMID: 32203977) Biochem J. 2004 Oct 1;383(Pt 1):45-51. (PMID: 15283675) Nat Rev Microbiol. 2019 Mar;17(3):181-192. (PMID: 30531947) Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264) Am J Obstet Gynecol. 2020 May;222(5):415-426. (PMID: 32105680) Autoimmun Rev. 2020 Jul;19(7):102571. (PMID: 32376402) JAMA Cardiol. 2020 Sep 1;5(9):1020-1026. (PMID: 32936273) Mayo Clin Proc. 2020 Sep;95(9):1946-1954. (PMID: 32861338) Int J Environ Res Public Health. 2020 Mar 06;17(5):. (PMID: 32155789) Amino Acids. 2015 Apr;47(4):693-705. (PMID: 25534429) Lancet. 2020 May 2;395(10234):e77-e78. (PMID: 32333843) J Infect. 2020 May;80(5):554-562. (PMID: 32169481) Occup Environ Med. 2020 May;77(5):281-282. (PMID: 32238444) Gastrointest Endosc. 2020 Jul;92(1):192-197. (PMID: 32179106) Ir J Med Sci. 2020 Nov;189(4):1155-1157. (PMID: 32394153) Transl Pediatr. 2020 Feb;9(1):51-60. (PMID: 32154135) Lancet Respir Med. 2019 Mar;7(3):e10. (PMID: 30823975) Allergy. 2020 Jul;75(7):1730-1741. (PMID: 32077115) Matern Child Nutr. 2020 Jul;16(3):e13010. (PMID: 32243068) J Crit Care. 2020 Jun;57:279-283. (PMID: 32173110) PLoS Pathog. 2018 Aug 13;14(8):e1007236. (PMID: 30102747) EMBO Mol Med. 2020 Jun 8;12(6):e12661. (PMID: 32379923) Cell Immunol. 2015 Apr;294(2):63-9. (PMID: 25682174) Int J Biol Sci. 2020 Mar 15;16(10):1753-1766. (PMID: 32226295) J Pathol. 2001 Jan;193(1):134-40. (PMID: 11169526) Cell. 2020 Apr 16;181(2):271-280.e8. (PMID: 32142651) Cell Death Dis. 2020 Jul 8;11(7):516. (PMID: 32641762) Lancet Psychiatry. 2020 Mar;7(3):228-229. (PMID: 32032543) Methods Mol Biol. 2015;1282:1-23. (PMID: 25720466) PLoS Med. 2011 Mar;8(3):e1001012. (PMID: 21445325) Vaccine. 2012 Nov 26;30(50):7300-8. (PMID: 23022401) Chest. 1992 Jul;102(1):208-15. (PMID: 1623755) J Med Virol. 2020 Sep;92(9):1556-1561. (PMID: 32222119) J Thorac Dis. 2016 Jan;8(1):E1-7. (PMID: 26904232) J Pediatr. 2020 Jul;222:221-226. (PMID: 32330469) EClinicalMedicine. 2020 Apr 24;22:100356. (PMID: 32337502) Clin Immunol. 2020 May;214:108393. (PMID: 32222466) Cardiovasc Res. 2020 Aug 1;116(10):1666-1687. (PMID: 32352535) Acta Paediatr. 2020 Jun;109(6):1082-1083. (PMID: 32212348) Front Public Health. 2020 Apr 29;8:152. (PMID: 32411652) PLoS Med. 2008 Mar 25;5(3):e74. (PMID: 18366252) |
| فهرسة مساهمة: | Keywords: COVID-19; SARS-CoV-2; environmental and occupational exposure; infection; molecular predisposition; risk-factors |
| تواريخ الأحداث: | Date Created: 20201029 Latest Revision: 20231112 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC7577231 |
| DOI: | 10.3389/fphar.2020.579415 |
| PMID: | 33117174 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!